多发性硬化(multiple sclerosis, MS)是一种常见的中枢神经系统炎性脱髓鞘疾病,好发于中青年,是成人神经性致残的主要原因。因其有较高的发病率、慢性病程和青壮年易患而备受关注。目前MS尚无有效的根治疗法,临床上仍以疾病修正治疗为主。因此探索新的治疗方法尤为重要。诱导性多能干细胞(induced pluripotent stem cells, iPSCs)具有干细胞的分化全能性,不仅成功避开了胚胎干细胞的伦理问题,同时也解决了干细胞来源受限的问题,有望成为MS的良好治疗方式。
Multiple sclerosis (MS) is a common inflammatory demyelinating disease of the central nervous system, which occurs in young and middle-aged people and is the main cause of neurological disability in adults. Because of its high morbidity, chronic course, and susceptibility to young adults, it has attracted much attention. At present, there is no effective root therapy for MS, and the disease correction therapy is still the main clinical practice. Therefore, it is particularly important to explore new treatment methods. Induced pluripotent stem cells (iPSCs) have stem cell differentiation totipotency, which not only successfully avoids the ethical problems of embryonic stem cells, but also solves the problem of limited stem cell sources. It is expected to become a good treatment for MS.
Multiple sclerosis (MS) is a common inflammatory demyelinating disease of the central nervous system, which occurs in young and middle-aged people and is the main cause of neurological disability in adults. Because of its high morbidity, chronic course, and susceptibility to young adults, it has attracted much attention. At present, there is no effective root therapy for MS, and the disease correction therapy is still the main clinical practice. Therefore, it is particularly important to explore new treatment methods. Induced pluripotent stem cells (iPSCs) have stem cell differentiation totipotency, which not only successfully avoids the ethical problems of embryonic stem cells, but also solves the problem of limited stem cell sources. It is expected to become a good treatment for MS.
郑钦日. 诱导性多能干细胞在多发性硬化中的研究现状Research Status of Induced Pluripotent Stem Cells in Multiple Sclerosis[J]. 临床医学进展, 2021, 11(01): 138-142. https://doi.org/10.12677/ACM.2021.111020
参考文献ReferencesNoseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000) Multiple Sclerosis. The New England Journal of Medicine, 343, 938-952. <br>https://doi.org/10.1056/NEJM200009283431307Compston, A. and Coles, A. (2008) Multiple Sclerosis. The Lancet, 372, 1502-1517.
<br>https://doi.org/10.1016/S0140-6736(08)61620-7Polman, C.H., Reingold, S.C., Banwell, B., et al. (2011) Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. Annals of Neurology, 69, 292-302. <br>https://doi.org/10.1002/ana.22366Poser, C.M. and Brinar, V.V. (2001) Diagnostic Criteria for Multiple Sclerosis. Clinical Neurology and Neurosurgery, 103, 1-11. <br>https://doi.org/10.1016/S0303-8467(00)00125-6Polman, C.H., Reingold, S.C., Edan, G., et al. (2005) Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the “McDonald Criteria”. Annals of Neurology, 58, 840-846. <br>https://doi.org/10.1002/ana.20703Almeida, S., Gascon, E., Tran, H., Chou, H.J., Gendron, T.F., et al. (2013) Modeling Key Pathological Features of Frontotemporal Dementia with C9ORF72 Repeat Expansion in iPSC-Derived Human Neurons. Acta Neuropathologica, 126, 385-399. <br>https://doi.org/10.1007/s00401-013-1149-ySong, B., Sun, G., Herszfeld, D., et al. (2012) Neural Differentiation of Patient Specific iPS Cells as a Novel Approach to Study the Pathophysiology of Multiple Sclerosis. Stem Cell Research, 8, 259-273.
<br>https://doi.org/10.1016/j.scr.2011.12.001Douvaras, P., Wang, J., Zimmer, M., et al. (2014) Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells. Stem Cell Reports, 3, 250-259.
<br>https://doi.org/10.1016/j.stemcr.2014.06.012Laterza, C., Merlini, A., De Feo, D., et al. (2013) iPSC-Derived Neural Precursors Exert a Neuroprotective Role in Immune-Mediated Demyelination via the Secretion of LIF. Nature Communications, 4, 2597.
<br>https://doi.org/10.1038/ncomms3597Wang, S., Bates, J., Li, X., et al. (2013) Human iPSC-Derived Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of Congenital Hypomyelination. Cell Stem Cell, 12, 252-264.
<br>https://doi.org/10.1016/j.stem.2012.12.002Takahashi, K. and Yamanaka, S. (2006) Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell, 126, 663-676. <br>https://doi.org/10.1016/j.cell.2006.07.024Tokumoto, Y., Ogawa, S., Nagamune, T. and Miyake, J. (2010) Comparison of Efficiency of Terminal Differentiation of Oligodendrocytes from Induced Pluripotent Stem Cells versus Embryonic Stem Cells in Vitro. Journal of Bioscience and Bioengineering, 109, 622-628. <br>https://doi.org/10.1016/j.jbiosc.2009.11.013Ogawa, S., Tokumoto, Y., Miyake, J. and Nagamune, T. (2011) Induction of Oligodendrocyte Differentiation from Adult Human Fibroblast-Derived Induced Pluripotent Stem Cells. In Vitro Cellular & Developmental Biology—Animal, 47, 464-469. <br>https://doi.org/10.1007/s11626-011-9435-2Pluchino, S., Quattrini, A., Brambilla, E., et al. (2003) Injection of Adult Neurospheres Induces Recovery in a Chronic Model of Multiple Sclerosis. Nature, 422, 688-694. <br>https://doi.org/10.1038/nature01552Yang, J., Yan, Y., Ciric, B., et al. (2010) Evaluation of Bone Marrow- and Brain-Derived Neural Stem Cells in Therapy of Central Nervous System Autoimmunity. The American Journal of Pathology, 177, 1989-2001.
<br>https://doi.org/10.2353/ajpath.2010.091203Sareen, D., O’Rourke, J.G., Meera, P., Muhammad, A.K., Grant, S., et al. (2013) Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion. Science Translational Medicine, 5, 208ra149.
<br>https://doi.org/10.1126/scitranslmed.3007529Donnelly, C.J., Zhang, P.W., Pham, J.T., Heusler, A.R., Mistry, N.A., et al. (2013) RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention. Neuron, 80, 415-428.
<br>https://doi.org/10.1016/j.neuron.2013.10.015Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M.O., Akhmanova, A., et al. (2007) Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates. Journal of Neuroscience, 27, 9801-9815.
<br>https://doi.org/10.1523/JNEUROSCI.2661-07.2007Plaisted, W.C., Zavala, A., Hingco, E., Tran, H., Coleman, R., Lane, T.E., Loring, J.F. and Walsh, C.M. (2016) Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis. PLoS ONE, 11, e0157620.
<br>https://doi.org/10.1371/journal.pone.0157620Zhang, C., et al. (2016) Treatment of Multiple Sclerosis by Transplantation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells. Science China Life Sciences, 59, 950-957. <br>https://doi.org/10.1007/s11427-016-0114-9Nicaise, A.M., et al. (2017) iPS-Derived Neural Progenitor Cells from PPMS Patients Reveal Defect in Myelin Injury Response. Experimental Neurology, 288, 114-121. <br>https://doi.org/10.1016/j.expneurol.2016.11.012